InnerCool enters Europe via Euromed
This article was originally published in Clinica
Executive Summary
Temperature modulation specialist InnerCool Therapies has enlisted cardiology products distributor Euromed Medizinisch to make its technology available in Europe for the first time. The exclusive deal, of which financial details were not disclosed, will see Vienna, Austria-based Euromed distribute the CoolBlue surface cooling temperature modulation system and the RapidBlue endovascular cooling system in Austria, Germany and Switzerland. The CoolBlue product was launched in the US during Q4 2007 and is expected to go on sale through Euromed this quarter. The RapidBlue device is set to go to the US market during the second quarter of 2008 and become commercially available third quarter. The deal with Euromed follows InnerCool's recent distribution deal with Lifehealthcare for the Australian and New Zealand markets. A spokesperson for InnerCool told Clinica that the company would be entering into further deals to strengthen its presence outside the US. San Diego, California-based InnerCool is a subsidiary of interventional cardiology specialist Cardium Therapeutics.